Pharnext SCA
OTC:PNEXF

Watchlist Manager
Pharnext SCA Logo
Pharnext SCA
OTC:PNEXF
Watchlist
Price: 999 999.9999 USD
Market Cap: 6T USD
Have any thoughts about
Pharnext SCA?
Write Note

Relative Value

There is not enough data to reliably calculate the relative value of PNEXF.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PNEXF Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
47
vs Industry
Median 3Y
36 960 367.5
Median 5Y
37 559 510.3
Industry
7.7
Forward
2 981 808
vs History
vs Industry
Median 3Y
-173 743.6
Median 5Y
-182 492.9
Industry
22.7
Forward
-5.2
vs History
vs Industry
Median 3Y
-226 949.4
Median 5Y
-231 362.7
Industry
21.6
vs History
vs Industry
Median 3Y
-850 452.7
Median 5Y
-534 714.6
Industry
25.2
vs History
vs Industry
Median 3Y
-179 541.9
Median 5Y
-233 970.4
Industry
2.5
vs History
47
vs Industry
Median 3Y
36 960 529.1
Median 5Y
37 559 671.9
Industry
7.7
Forward
2 981 820.7
vs History
vs Industry
Median 3Y
-142 663 656.2
Median 5Y
-70 035 358.6
Industry
9
vs History
vs Industry
Median 3Y
-211 941.9
Median 5Y
-237 888
Industry
4.2
Forward
-232 907.7
vs History
vs Industry
Median 3Y
-209 523.3
Median 5Y
-229 827
Industry
4.1
Forward
-231 880
vs History
vs Industry
Median 3Y
-226 950.4
Median 5Y
-231 363.8
Industry
5.7
vs History
vs Industry
Median 3Y
-226 381.4
Median 5Y
-230 783.7
Industry
3.6
vs History
vs Industry
Median 3Y
13 145.1
Median 5Y
1 665 007.8
Industry
4.6

Multiples Across Competitors

PNEXF Competitors Multiples
Pharnext SCA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 888 840.5 -180 080 -218 674.5 -216 179.2
US
Abbvie Inc
NYSE:ABBV
314.4B USD 5.7 61.9 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117B USD 11 -243 24.2 25.5
US
Gilead Sciences Inc
NASDAQ:GILD
112.5B USD 4 892.3 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 859.4 -474.5 -516.7 -502.9
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.3B USD 6 17.7 16.1 17.9
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.9 -59 -53.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.6 -105.1 -76.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
31.8B USD 15.2 -95.6 -227.4 -159.8
P/E Multiple
Earnings Growth
FR
Pharnext SCA
OTC:PNEXF
Average P/E: 208.4
Negative Multiple: -180 080
N/A
US
Abbvie Inc
NYSE:ABBV
61.9
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -243
42%
US
Gilead Sciences Inc
NASDAQ:GILD
892.3
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.6 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -95.6 N/A
EV/EBITDA Multiple
EBITDA Growth
FR
Pharnext SCA
OTC:PNEXF
Average EV/EBITDA: 17.2
Negative Multiple: -218 674.5
N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.2
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.1
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -227.4 N/A
EV/EBIT Multiple
EBIT Growth
FR
Pharnext SCA
OTC:PNEXF
Average EV/EBIT: 22.6
Negative Multiple: -216 179.2
N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.5
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -159.8 N/A

See Also

Discover More
Back to Top